IHE Innovation Forum III - Maximizing Health System Performance (1)

Maximizing Health System Performance (1): Key People

Speaker Biographies

Keynote Speakers

Dr. Robert Brook

Dr. Robert Brook, M.D., Sc.D., F.A.C.P is Vice-President and Director of RAND Health, Professor of Medicine at the David Geffen School of Medicine and Professor of Health Services at the School of Public Health at the University of California, Los Angeles, where he also directs the Robert Wood Johnson Clinical Scholars Program. A board-certified internist, he received his M.D. and Sc.D. degrees from Johns Hopkins University. He has been on the medical school faculty at UCLA since 1974, and divides his research time between UCLA and RAND. A prolific scholar, Bob has published over 300 peer reviewed articles in the course of his long and productive career. He conducted pioneering work in the field of quality measurement. He operationalized the concept of appropriateness by establishing the scientific basis for determining whether various medical and surgical procedures were being used appropriately. More than any other individual, he is responsible for focusing policymakers’ attention on quality-of-care issues and their implications for the nation’s health. Most of the quality of care and health status measures being used today throughout the developed world were developed by Bob or by research teams that he led.

Bob has received numerous professional honors, including the Peter Reizenstein Prize, 2000, for his paper “Defining and Measuring Quality of Care: A Perspective from US Researchers,” the National Committee for Quality Assurance Health Quality Award for pursuit of health care quality at all levels of the health system, Research! America’s 2000 Advocacy Award for Sustained Leadership at the National Level, the Robert J. Glaser Award of the Society of General Internal Medicine, the Richard and Hinda Rosenthal Foundation Award of the American College of Physicians, and the Distinguished Health Services Research Award of the Association of Health Services Research. He is an elected member of many professional organizations, including the Institute of Medicine, the American Association of Physicians, the Western Association of Physicians, and the American Society for Clinical Investigation. He was selected as one of 75 Heroes of Public Health by Johns Hopkins University and is a member of the Johns Hopkins Society of Scholars. In 2005, Bob was awarded the Institute of Medicine's prestigious Gustav O. Lienhard Award for the advancement for personal health care services in the United States. In 2002, Bob was named chair of a panel to advise the Office of Statewide Health Planning and Development on how to report outcomes of coronary artery bypass graft surgery at California hospitals. In 2007 Bob received the David E. Rogers Award from the Association of American Medical Colleges. This award recognizes a medical school faculty member who has made major contributions to improving the health and health care of the American people.

Mr. Jeff Lozon

Jeffrey C. (Jeff) Lozon is a health care professional with more than 20 years’ experience in leading large health care systems and academic health sciences centres in Canada. In June of 2009 he became President and CEO of ReveraLiving – a major provider of long term and residential care services. Prior to that Jeff was with the St. Michael’s Hospital as Executive Vice-President and Chief Operating Officer. In 1999, he was seconded to serve as Deputy Minister of Health and Long-Term Care for the Province of Ontario for a year. In 2000 He returned to St. Michael’s Hospital as President and Chief Executive Officer. He led St. Michael’s Hospital through a major financial and strategic turnaround, which included eliminating a debt of $63 million, and positioning the hospital as a model of fiscal responsibility, management and patient care. During his appointment at St. Michael’s Hospital, Mr. Lozon has sat on the Board of Directors for a variety of organizations. Mr. Lozon is a member of the Board of Directors for Canada’s Top 40 Under 40 and for the University of Guelph. He also serves on the provincial Panel On The Future Role of Government and as the Vice Chair of Canada Health Infoway, which is responsible for the development of a Pan Canadian Electronic Health Record. From 2006 – 2009 he was appointed by the Prime Minister as the inaugural Chair of the Canadian Partnership Against Cancer.

Mr. Lozon is an Associate Professor in the Department of Health Administration at the University of Toronto. In the past, he has held other faculty positions at the University of Alberta and the University of Saskatchewan. Mr. Lozon has held executive positions at some of Canada’s most well-known health care institutions and agencies. From 1987 to 1991, he served as President and Chief Executive Officer of the Glenrose Rehabilitation Hospital in Alberta, Canada’s largest specialty rehabilitation referral centre, where a new, state-of-the-art facility was completed on budget and ten months early during his term. From 1985 to 1987, he was the Executive Director of the Manitoba Health Organizations Inc., which represents 220 active treatments and long-term care health facilities. In 1998, Mr. Lozon was the recipient of the CEO Award of Excellence in Communications, presented by the International Association of Business Communicators, to recognize leadership in executive commitment to communications.


Dr. Philip Baker

Dr. Philip Baker became the Dean of the Faculty of Medicine & Dentistry at the University of Alberta effective September 1, 2009.

Prior to joining the Faculty of Medicine & Dentistry, Dr. Baker was director of the Manchester Biomedical Research Centre - a facility associated with the National Institute of Health Research in the United Kingdom - and Professor of Maternal and Fetal Health at St. Mary's Hospital at the University of Manchester. Dr. Baker trained in Nottingham, U.K., Pittsburgh, Pa., and Cambridge, U.K. From 1989 to 1991, he sat as the British Heart Foundation Clinical Research Fellow before continuing his training at the University of Cambridge. Dr. Baker returned to Nottingham for two years and then accepted the American College of Obstetricians and Gynecologists Travelling Research Fellowship at the Magee-Womens Research Institute in Pittsburgh.

In 1995, he again returned to Nottingham where he would remain until 2001, splitting duties as Professor of Obstetrics and Gynecology and as the head of the City hospital division of the School of Human Development. Dr. Baker moved to the University of Manchester in 2001 to direct the newly established Maternal and Fetal Health Research Centre, where he was instrumental in fostering collaborations and interactions between scientists and health-care providers. He served as Associate Dean for Research within the Faculty of Medical and Human Sciences, and both Associate Head and Head of the medical school in Manchester, the largest in Europe. Dr. Baker is well known for his work as an obstetrician scientist. His research focuses on pregnancy complications, including miscarriage, preeclampsia, preterm labour, fetal growth restriction and stillbirth. His major research contribution has been to increase understanding of the life-threatening complication pre-eclampsia and develop therapeutic strategies.

He has written more than 200 scientific publications, more than 50 review articles and 14 books. He edits the journal Current Opinion in Obstetrics and Gynecology. His prizes and awards include the 2004 Sir William Liley Lectureship (Perinatal Research Society) and the 2005 President's Achievement Award of the Society of Gynecologic Investigation, the first time this award had been made outside North America. In 2008 he was elected to the Academy of Medical Sciences.

Dr. Stephen Duckett

Dr. Stephen Duckett has spent his professional life working in health care. As Alberta Health Services' new President and Chief Executive Officer (effective March 23, 2009). Dr. Duckett has more than 35 years of experience in health care.

Prior to coming to Alberta, Dr. Duckett was Chief Executive Officer of the Centre for Healthcare Improvement for Queensland Health in Australia. (Queensland occupies the north east of the Australian continent and is roughly triple the size of Alberta; Queensland health is the public provider with approximately 60,000 staff.)

Before that, he was a professor of Health Policy and Dean of the Faculty of Health Sciences for 10 years at La Trobe University in Melbourne. He also chaired the board of a major public health provider, Alfred Health. Dr. Duckett's work in health care also includes two years with the Government of Australia as Secretary (equivalent to Deputy Minister) to the Department of Human Services and Health.

In 2006, Dr. Duckett received a Doctor of Business Administration in Higher Education Management from the University of Bath in the United Kingdom. That same year, he also received a Doctor of Science Award based on his publications from the University of New South Wales in Sydney, Australia. Dr. Duckett has a PhD in Health Administration from the University of New South Wales and a Bachelor of Economics (Economics and Pure Mathematics) from the Australian National University in Canberra, Australia.

Dr. Tom Feasby

Dr. Tom Feasby has been Dean of the Faculty of Medicine at the University of Calgary since 2007. Previously he was Vice-President of Academic Affairs at Capital Health and Associate Dean in the Faculty of Medicine at the University of Alberta. He is a practicing neurologist and a health services researcher, who studies the appropriateness of health care interventions. Dr. Feasby has been a long time member of the Institute of Health Economics Board and was recently appointed to serve on the Minister’s Advisory Committee on Health. He completed his BSc and MD at the University of Manitoba, followed by a research fellowship at Institute of Neurology in London, England and professorships in neurology at the University of Western Ontario in London, Ont. From 1991 to 2003, while leading the U of C Faculty of Medicine's Department of Clinical Neurosciences, he was also head of the Calgary Health Region's regional Department of Clinical Neurosciences, where he assembled an internationally-recognized clinical neurosciences group.

His record of research excellence is reflected in more than 100 research publications in areas such as neurologic diseases and the appropriateness of health care interventions, his supervision of numerous graduate students, and his involvement in professional societies and organizations including the CIHR Institute of Health Services and Policy Research, the Canadian Academy of Health Sciences and the American Academy of Neurology.

Mr. Fred Horne

Mr. Fred Horne was elected to his first term as a Member of the Legislative Assembly for Edmonton-Rutherford on March 3, 2008. In addition to his regular duties as MLA, Mr. Horne serves as chair of the Standing Committee on Health, deputy chair of the Premier’s Council on the Status of Persons with Disabilities and is a member of the Agenda and Priorities Committee, Private Members Business Committee, Legislative Offices Committee and the Select Special Chief Electoral Officer Search Committee. Prior to serving with the Legislative Assembly of Alberta, Mr. Horne worked as a health policy consultant for over 25 years, serving various government bodies and regional health authorities in addition to the public, private and not-for-profit sectors.

Throughout his career Mr. Horne led initiatives to improve access and quality in Canadian public health care and has worked extensively with the Conference Board of Canada, the Alberta government and the Mayo Clinic. An avid volunteer, Mr. Horne has served on numerous boards including: Alberta Mental Health Board, Athabasca University, Mediation and Restorative Justice Centre of Edmonton, Canadian Student Debating Federation. Additionally, Mr. Horne is a former debater and coached Team Canada at the World Schools Debating Championships. For his continued contributions to the development of debate and speech programs Mr. Horne received the Queen Elizabeth II Golden Jubilee Medal in 2002. Mr. Horne and his wife, Jennifer, have lived in Edmonton since 1992.

Ms. Linda Miller

Linda was appointed the Deputy Minister of Alberta Health and Wellness on December 10, 2008 where she is responsible for the leadership to assure the delivery of health services to Albertans.

Linda obtained her Masters of Health Services Administration, Baccalaureate Degree in Nursing and Certificate in Information Technology Management from the University of Alberta. She earned her Diploma in Nursing from the Royal Alexandra School of Nursing.

Linda has been with the Department of Alberta Health and Wellness since 1994. Her previous post was as the Assistant Deputy Minister of Information Strategic Services where she was responsible for leading the strategic planning process for new information system development in the Ministry and for overseeing the provincial implementation of the Electronic Health Record.

Dr. Lorne Tyrrell

Lorne Tyrrell is the Chair of the Board, Institute of Health Economics. He is the CIHR/GlaxoSmithKline Chair in Virology at the University of Alberta. Dr. Tyrrell is also the Chair of the Board of the Alberta Health Quality Council and Chair of the Gairdner Foundation and a member of the Research Council of the Canadian Institute of Academic Research. In 2004, Dr. Tyrrell completed 10 years as the Dean of the Faculty of Medicine and Dentistry at the University of Alberta.

Dr. Tyrrell has won numerous awards at the University of Alberta (Rutherford Undergraduate Teaching Award, J. Gordin Kaplan Research Awards, and the University Cup). He won the ASTech Award for Research in 1993 and the Gold Medal of the Canadian Liver Foundation in 2000.

Dr. Tyrrell was appointed to the Alberta Order of Excellence in 2000, an Officer of the Order of Canada in 2002, and a Fellow of the Royal Society of Canada in 2004. He was awarded the F.N.G. Starr Award from the Canadian Medical Association in 2004 and the Principal Award of the Manning Foundation in 2005 for his work on the development of oral antivirals for the treatment of HBV.